Literature DB >> 31663996

The Role of Sex on Early Cochlear Implant Outcomes.

Mallory J Raymond1, Samir A Ballestas1, Justin C Wise2, Esther X Vivas1.   

Abstract

OBJECTIVE: To determine the presence of sex differences in cochlear implant outcomes. STUDY
DESIGN: Retrospective chart review.
SETTING: Tertiary referral center. PATIENTS: Adult patients having undergone cochlear implantation from 2009 to 2017. INTERVENTION(S): Standard electrode length cochlear implantation. MAIN OUTCOME MEASURE(S): AzBio scores in quiet of the implanted ear at the 1 to 3 months and 6 to 9 months postoperative time points.
RESULTS: Of 55 patients with complete demographic and speech recognition testing, 36.4% (n = 20) were men. The mean age at time of surgery was 59.81 ± 16.54 years and the mean duration of hearing loss was 26.33 ± 18.54 years; there was no significant difference between men and women. The mean preoperative AzBio score was 11 ± 15.86% and there was no difference between men and women. Through 2 (sex) × 3 (time point) analysis of covariance (ANCOVA), there was no main effect of sex (F[1, 48] = 0.74, p = 0.39, η = 0.02) on postoperative AzBio scores, but there was a significant sex by time point interaction, (F[1.77, 85.03] = 4.23, p = 0.02, η = 0.08). At the 1 to 3 months postoperative time point, women exhibited higher relative improvement in AzBio scores than men (67 ± 27% versus 55 ± 31%). Further, this relative improvement increased and remained significant at the 6 to 9 months postoperative time point (women: 71 ± 22% versus 58 ± 30%).
CONCLUSIONS: Sex may play a role in early speech recognition outcomes after adult cochlear implantation.

Entities:  

Mesh:

Year:  2019        PMID: 31663996     DOI: 10.1097/MAO.0000000000002402

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  1 in total

1.  Review of Speech Outcomes in Cochlear Implant Recipients at a Nascent Cochlear Implant Program.

Authors:  Nathan Aminpour; Laura Levin; Mary Finkbone; Michael Morikawa; Melissa Blumgart; H Jeffrey Kim; Michael Hoa
Journal:  Cureus       Date:  2022-02-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.